El camino para liberar al cannabis en México sigue siendo de espinas. El trámite burocrático requiere de un reglamento para permitir operar que, de momento se dilata.
Es que, según informa El Heraldo, se reprogramó el plazo para que la Secretaría de Salud y Cofepris, la agencia que regula los consumos de la población, elaboren el tan esperado reglamento sobre cannabis.
El plazo que dio la corte para elaborar el reglamento fue de 180 días.
El Poder Judicial reactivó el plazo que obliga a la secretaría de Salud y a la Cofepris a elaborar un reglamento que permita el uso de medicamentos con cannabis, esto como resultado de la sentencia emitida por la Suprema Corte de Justicia de la Nación, a favor de un amparo presentado por una familia el año pasado.
El amparo en revisión 57/2019 fue presentado por unos padres de familia para que su hijo, un menor de edad, accediera de manera urgente a un tratamiento basado en aceite de cannabidiol (CBD), útil contra la epilepsia isquémica cerebral, entre otras cosas.
Posteriormente, recordó la secretaría de Salud en un comunicado, el Acuerdo fue reformado para ampliar la suspensión hasta el 30 de junio, con la misma excepción.
Sin embargo, hace unos días el juzgado de conocimiento determinó que la sentencia del amparo en revisión 57/2019 se considera como caso urgente y la secretaría de Salud fue notificada el 9 de junio sobre esta definición, informó la propia dependencia.En ese sentido, la dependencia recordó que de manera inicial fue notificada de la sentencia el 9 de septiembre de 2019, por lo que aseguró que la fecha aproximada de vencimiento del plazo es el 9 de septiembre de 2020.
Añadió que “todas las áreas de la Secretaría seguimos trabajando en el tema, para dar cumplimiento a esta sentencia”.
La dependencia encabezada por Jorge Alcocer describió que a partir de la notificación de la sentencia el año pasado, la Oficina del Abogado General de la Secretaría de Salud requirió al titular de Cofepris, José Alonso Novelo y a su Coordinador General Jurídico y Consultivo.
Lo hizo “a fin de llevar a cabo, de forma prioritaria y urgente, los trabajos relativos a la armonización de la normatividad tendientes a dar cumplimiento a la sentencia, contando con la participación de la Subsecretaría de Prevención y Promoción de la Salud, la Comisión Nacional contra las Adicciones, Servicios de Atención Psiquiátrica, y demás áreas sustantivas de la Secretaría en la materia”.
LUPA RUBRA
The path to liberate cannabis in Mexico continues to be one of thorns. The bureaucratic process requires a regulation to allow it to operate, which is currently being expanded.
Is that, according to El Heraldo reports, the deadline for the Ministry of Health and Cofepris, the agency that regulates the consumption of the population, to draft the long-awaited regulation on cannabis is reprogrammed.
The term given by the court to prepare the regulation was 180 days.
The Judiciary reactivated the term that obliges the Ministry of Health and the Cofepris to elaborate a regulation that allows the use of drugs with cannabis, this as a result of the sentence issued by the Supreme Court of Justice of the Nation, a favor of a amparo filed by a family last year.
The amparo under review 57/2019 was presented by the parents so that their minor child urgently agreed to a treatment based on cannabidiol oil (CBD), useful against cerebral ischemic epilepsy, among other things.
What hinders access to these treatments is that the Ministry of Health and the Federal Commission for the Protection against Health Risks (Cofepris) have not issued the regulation to allow the use of drugs of this class based on cannabis.
What hinders access to these treatments is that the Ministry of Health and the Federal Commission for the Protection against Health Risks (Cofepris) have not issued protocols to allow the use of these cannabis-based drugs.
The term given by the court to prepare the regulation was 180 days (end of December), recalled the Ministry of Health, an agency that ensured that they continue to work to create such regulations.
Due to the health emergency due to COVID-19, the Federal Judicial Council had suspended the activities of the jurisdictional bodies since March 18 and therefore, as of that date, the procedural terms and terms would not run, except for matters urgent.
Later, the Ministry of Health recalled in a statement, the Agreement was amended to extend the suspension until June 30, with the same exception.
However, a few days ago the court of knowledge determined that the judgment of amparo under review 57/2019 is considered as an urgent case and the Ministry of Health was notified on June 9 of this definition, the agency itself reported.
"In that tenor, the term of 180 working days to create the rules for the medicinal use of cannabis, continues to run again from June 10, 2020, the date on which the notification of the aforementioned agreement took effect" argued the secretariat it´s a statement .
In this sense, the agency recalled that it was initially notified of the sentence on September 9, 2019, so it assured that the approximate expiration date of the term is September 9, 2020.
He added that "all areas of the Secretariat continue to work on the issue, to comply with this judgment."
The agency headed by Jorge Alcocer described that from the notification of the sentence last year, the Office of the Attorney General of the Ministry of Health required the head of Cofepris, José Alonso Novelo and its General Legal and Advisory Coordinator.
It did so "in order to carry out, as a priority and urgent matter, the work related to the harmonization of the regulations aimed at complying with the judgment, with the participation of the Undersecretariat for Prevention and Promotion of Health, the Commission National Against Addictions, Psychiatric Care Services, and other substantive areas of the Secretariat in the matter.
LUPA RUBRA
